Literature DB >> 7398780

Antihistamine effect on synaptosomal uptake of serotonin, norepinephrine and dopamine.

P A Brown, J Vernikos.   

Abstract

The nature and specificity of the effect of histamine H1- and H2-receptor antagonists on the uptake of serotonin (5HT), norepinephrine (NE) and dopamine (DA) were studied in rat forebrain synaptosomes. Low concentrations (0.05-0.50 microM) of the H1-antagonist, pyrilamine, competitively inhibited 5HT uptake (Ki = 0.09 microM), had little effect on NE uptake and no effect on DA uptake. At the same concentrations, two other H1 antihistamines, promethazine and diphenhydramine, and two H2-antihistamines, metiamide and cimetidine, had no effect on 5HT or DA uptake. Diphenhydramine had a small inhibitory effect on NE uptake. It is concluded that at low concentrations, pyrilamine is a relatively selective and potent competitive inhibitor of 5HT uptake, an action which is uncharacteristic of several other antihistamines.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7398780     DOI: 10.1016/0014-2999(80)90213-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Comparison of the effects of eleven histamine H1-receptor antagonists on monoamine turnover in the mouse brain.

Authors:  R Oishi; S Shishido; M Yamori; K Saeki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-02       Impact factor: 3.000

2.  H1-receptor antagonists: comparative pharmacology and clinical use.

Authors:  D Reinhardt; U Borchard
Journal:  Klin Wochenschr       Date:  1982-09-01

3.  In vivo effects of some histamine H1-receptor antagonists on monoamine metabolism in the mouse brain.

Authors:  S Shishido; R Oishi; K Saeki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

4.  Effects of trepelennamine on brain monoamine turnover in morphine dependent and abstinent mice.

Authors:  O San-Martin-Clark; B Cuellar; J C Leza; I Lizasoain; P Lorenzo
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.